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EEG with co-registered electrocardiography was recorded during at least two interictal epiteptiform EEG 
discharges in each of 11 patients who later suffered from sudden unexpected death in epilepsy (SUDEP), and from 
another 11 age and sex matched patients, also with uncontrolled tonic-clonic seizures, drawn from the same centre 
who were still alive at the time of investigation (non-SUDEPs). A corrected QT interval for rate (QTc) was 
obtained and a mean value calculated for the period immediately prior to discharge, during discharge and 
immediately post discharge. Mean QTc was also obtained interictally without discharge. There was a significant 
(P = 0.01) increase in the mean QTc during discharge compared to that measured interictally without discharge for 
the whole population of SUDEPs and non-SUDEPs, and this was maintained for the SUDEPs alone (P = 0.02) but 
did not hold for the non-SUDEP group alone. Although reaching statistical significance, increases in mean QTc in 
SUDEP patients only exceeded currently accepted upper limits in one case, and then only marginally. The clinical 
significance of these findings merits further investigation. 
Key words: epilepsy; sudden unexplained eath; electrocardiography; QTc interval; interictal epileptiform 
discharge; EEG. 
INTRODUCTION 
Epilepsy carries an increased mortality risk of 
approximately two or three times the general 
population t-3. A proportion of these deaths may 
be due to suicide, accident, or convulsive status 
epilepticus 4~. However, there remains a group of 
people with epilepsy who die suddenly, in 
otherwise apparently good health, from a cur- 
rently unknown cause or causes. This phenome- 
non is referred to as sudden unexplained eath in 
epilepsy, or SUDEP 7'8. A recent Canadian study 
found the annual incidence of death as a 
complication of seizures to be 2.68 in 100000 
population 9.These deaths are typically associated 
with a tonic-clonic seizure, and are more likely to 
occur in patients who continue to have seizures 
despite treatment 6m. It is possible that a cardiac 
arrhythmia may be the terminal event in 
SUDEP~ H4. Experimental evidence from animal 
models of epilepsy has shown that interictal EEG 
epileptiform discharges can be associated with 
changes in the electrocardiogram (ECG), includ- 
ing alteration in the length of the QT interval, and 
development of cardiac arrhythmia ~2"~5-~8. 
This study set out to test the hypothesis that 
patients who later suffer SUDEP have a transient 
increase in the QT interval during an EEG 
epileptiform discharge which predisposes them to 
ventricular fibrillation and sudden death tg. This 
was tested by examining the QT interval, 
corrected for rate (QTc), before, during and 
immediately after interictal EEG epileptiform 
discharge in eleven cases of SUDEP on whom 
ambulatory EEG with co-registered ECG had 
been performed prior to death. 
METHOD 
Eleven cases of SUDEP occurring at the David 
Lewis Centre between 1989 and 1993 had 
previously had ambulatory EEG and co- 
registered ECG recordings. The diagnosis of 
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SUDEP was made on clinical grounds, confirmed 
by post-mortem findings where available (6/11 
cases). The recordings dated from less than one to 
thirty one months prior to death (mean, 13 
months). 
In all 11 cases, two recordings of interictal EEG 
epileptiform discharges with co-registered ECG 
were examined. An 8-second interictal EEG and 
ECG record, without epileptiform discharge and 
at least 1 hour away from a discharge or seizure, 
was also examined for each case. The onset and 
end of the EEG epileptiform discharge were 
determined by an experienced EEG technician 
'blind' to the proposed ECG analysis. The ECG 
recording, during EEG epileptiform discharge, 
was divided into three sections corresponding to
immediately before, during and immediately after 
the discharge. The pre EEG epileptiform dis- 
charge ECG record comprised the three ECG 
complexes occurring immediately before the 
onset of the discharge (a period of about 2 
seconds). The during EEG discharge record 
commenced with the first complete ECG complex 
(P wave, QRS complex and T wave) following the 
onset of EEG discharge and contained an average 
of eight ECG complexes (about 6 seconds). The 
post-EEG epileptiform discharge record con- 
sisted of a minimum of three ECG complexes 
occurring immediately after the end of the 
discharge. A corrected QT interval for rate (QTc) 
was obtained for each ECG complex by the 
method of Bazett 2° and a mean QTc value 
calculated for pre EEG discharge, during EEG 
discharge and post EEG discharge sections. QTc 
values and mean were also obtained for the eight 
second rhythm strip without EEG epileptiform 
activity. 
A controlled sample matched for age, sex, 
presence of tonic-clonic seizures and uncon- 
trolled epilepsy was drawn randomly from pati- 
ents investigated at the David Lewis Centre who 
were still alive (the non-SUDEP group). 
For each case and control the mean QTc was 
calculated for each of the four conditions (before, 
during, after and between discharges). Applica- 
tion of Shapiro-Wilk test for normality suggested 
that non-parametric statistical evaluation was 
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appropriate, and so comparisons were tested for 
significance using the Wilcoxon signed rank test. 
RESULTS 
Table 1 shows the duration of the EEG 
discharge in SUDEPs and non-SUDEPs. There 
was no statistically significant difference between 
these two groups. Table 2 shows the mean and 
range of QTc values for the 11 SUDEPs without 
EEG epileptiform discharge, immediately pre, 
during and post EEG epileptiform discharge. 
Table 3 shows the same for the non-SUDEPs. 
SUDEP and non-SUDEP data taken together 
showed a significant increase (P =0.01) in QTc 
from between-discharge to during-discharge 
state. For the non-SUDEPs alone, however, 
although the mean QTc did increase during all 
three conditions, this was not statistically sig- 
nificant, whereas for the SUDEPs, mean QTc 
rose significantly (Wilcoxon 2-tailed P=0.02) 
during an epileptiform discharge. Changes pre- 
and post discharge for SUDEPs were not 
significant, although there was a suggestion of a 
trend (P = 0.07) for increase from pre-discharge 
to during-discharge state (Table 4). 
The change from between-discharge to during- 
discharge states for SUDEPs and non-SUDEPs is 
shown in Fig. 1. In this it will be seen that the 
SUDEPs include one outlier. Re-analysis exclud- 
ing this outlier and its matched non-SUDEP 
control still gave a significant difference in the 
SUDEP group (P=0.03) but not in the non- 
SUDEP group. 
DISCUSSION 
The cause, or causes if aetiologically heteroge- 
neous, of SUDEP remains unknown. However a 
cardiac arrhythmia is considered to be a likely 
cause in at least some cases and for these, an 
increase in QTc may be a factor predisposing to 
arrhythmia. We have shown a small, but statisti- 
cally significant, increase in the mean OTc 
during interictal EEG epileptiform discharge 
Table 1: Duration of EEG epileptiform discharges (seconds) 
Mean Standard Range 
deviation 
SUDEPs 6.38* (8 ECG complexes) 10 .58  0.38-47.51 
non-SUDEPs 5.65* (8 ECG complexes) 2.38 0.64-8.08 
* Differences not significant both for duration of EEG discharge and number 
of ECG complexes. 
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Table 2: Mean and range of QTc (in seconds) for SUDEP cases 
SUDEPs No EEG Pre EEG During EEG Post EEG 
discharge discharge discharge discharge 
1 (female) 0.40 (0.36-0.42) 0.32 (0.30-0.32) 0.40 (0.36-0.42) 0.32 (0.30-0.34) 
2 (female) 0.47 (0.44-0.50) 0.48 (0.46-0.49) 0.48 (0.41-0.54) 0.47 (0.43-0.50) 
3 (female) 0.38 (0.36-0.40) 0.37 (0.34-0.40) 0.41 (0.37-0.45) 0.38 (0.35-0.45) 
4 (male) 0.35 (0.35-0.38) 0.39 (0.37-0.42) 0.37 (0.36-0.39) 0.35 (0.34-0.36) 
5 (male) 0.32 (0.29-0.35) 0.34 (0.30-0.38) 0.36 (0.33-0.38) 0.34 (0.31-0.36) 
6 (male) 0.38 (0.37-0.40) 0.38 (0.35-0.42) 0.36 (0.34-0.40) 0.41 (0.37-0.45) 
7 (male) 0.35 (0.32-0.37) 0.36 (0.34-0.39) 0.36 (0.35-0.38) 0.39 (0.37-0.42) 
8 (female) 0.36 (0.33-0.37) 0.37 (0.35-0.40) 0.37 (0.29-0.45) 0.44 (0.41-0.47) 
9 (female) 0.37 (0.36-0.40) 0.37 (0.34-0.39) 0.40 (0.35-0.42) 0.35 (0.35-0.36) 
10 (female) 0.34 (0.32-0.36) 0.34 (0.33-0.35) 0.35 (0.34-0.38) 0.36 (0.34-0.37) 
I I (female) 0.36 (0.35-0.36) 0.35 (0.32-0.39) 0.38 (0.33-0.44) 0.37 (0.33-0.42) 
compared to a between discharge state in patients 
who later died of SUDEP.  The change in an age 
and sex matched non-SUDEP group from the 
same centre still alive at the time of investigation, 
also with uncontrol led epilepsy was not 
significant. The currently accepted upper limit for 
QTc is 0.39 for males and 0.44 for females TM and in 
only one of the cases (case 2) did the mean QTc 
value with and without EEG discharge exceed 
this. 
Yet there are reasons why our data might 
underestimate the significance of QT  changes in 
predisposition to SUDEP:  
(1) Our  non-SUDEP group consisted of people 
who happen to still be alive, but we do not 
know how many of them might be at risk of 
SUDEP in the future. If this group contains 
some potential SUDEPs  then differences 
between SUDEP and non-SUDEP data 
might be minimised. 
(2) SUDEP may well have a heterogeneous 
aetiology with only some cases being pre- 
cipitated by an arrhythmia or being in- 
fluenced by an increase in QTc so that our 
case data may be diluted. 
(3) If EEG discharges only infrequently affect 
mean QTc significantly, as only two dis- 
charges per case were analysed, clinically 
significant change may have been missed by 
this study. 
(4) Finally, the change in QTc may be typically 
Table 3: Mean and range of QTc (in seconds) for non-SUDEPs 
Non-SUDEPs No EEG Pre EEG During EEG Post EEG 
discharge discharge discharge discharge 
1 (female) 0.37 -0.33-0.40) 0.37 (0.35-0.41) 0.40 (0.36-0.47) 0.43 (0.37-0.47) 
2 (female) 0.41 (0.40-0.43) 0.41 (0.39-0.43) 0.41 (0.39-0.46) 0.43 (0.39-0.44) 
3 (female) 0.34 (0.32-0.38) 0.35 (0.31-0.38) 0.34 (0.32-0.37) 0.33 (0.32-0.38) 
4 (male) 0.39 (0.37-0.40) 0.39 (0.33-0.41) 0.38 (0.37-0.39) 0.39 (0.38-0.40) 
5 (male) 0.34 (0.30-0.37) 0.35 (0.33-0.41) 0.35 (0.32-0.38) 0.35 (0.33-0.36) 
6 (male) 0.33 (0.33-0.34) 0.40 (0.38-0.41) 0.40 (0.36-0.42) .0.39 (0.38-0.41) 
7 (male) 0.35 (0.32-0.36) 0.34 (0.32-0.35) 0.34 (0.32-0.36) 0.34 (0.32-0.36) 
8 (female) 0.38 (0.34-0.41) 0.35 (0.33-0.36) 0.34 (0.32-0.39) 0.34 (0.33-0.36) 
9 (female) 0.37 (0.35-0.39) 0.39 (0.39) 0.40 (0.39-0.42) 0.42 (0.39-0.44) 
10 (female) 0.35 (0.31-0.38) 0.41 (0.39-0.42) 0.38 (0.31-0.48) 0.34 (0.30-0.39) 
I 1 (female) 0.41 (0.36-0.44) 0.43 (0.41-0.43) 0.42 (0.39-0.46) 0.42 (0.40-0.44) 
Table 4: Probabilities (Wilcoxon 2-tailed) 
Pre-disctiarge During discharge Post-discharge 
SUDEPs & non-SUDEPs combined 
Between discharge NS 0.01 
Pre-discharge NS 
During discharge 
SUDEPS only 
Between discharge NS 0.02 
Pre-discharge 0.07 
During discharge 
NS 
NS 
NS 
NS 
NS 
NS 
All non-SUDEP alone comparisons were non-significant. 
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Fig. 1: QTc change during EEG epileptiform discharges. 
small and either clinically insignificant or 
significant only in the presence of other 
factors which either prolong QTc, such as 
phenothiazines or hypokalaemia 2t, or predis- 
pose to an arrhythmia, such as catecholamine 
release 22, as may occur during a seizure t4. 
All these cases, both SUDEPs and non- 
SUDEPs, survived their epileptiform discharges 
at the time of recording, and we still know 
nothing of the events at the time of death. Given 
the propensity for QTc to increase during these 
non-fatal EEG discharges it is possible that on 
other occasions (perhaps associated with another 
intervening variable) QTc might increase further 
to a point where ventricular tachyarrhythmia 
could occur. These recordings were made using 
one-channel ECG approximating to standard 
lead II. A more accurate assessment of QT 
interval can be made using all 12 leads 23, but it has 
not been technically possible to obtain this 
information relating to ECG changes during 
these EEG discharges. We also lack any record to 
date of simultaneous EEG and ECG recording 
where SUDEP actually occurred. 
These findings raise the issue of whether 
prophylactic anti-arrhythmic medication such as 
beta-blockers might act protectively in people 
identified as at risk by this method. 
CONCLUSION 
A statistically significant increase for QTc 
values during EEG epileptiform discharge has 
been demonstrated bythis study for a group who 
subsequently died of sudden unexplained eath, 
but not for a comparable group who are still alive. 
However the study population is relatively small 
so that the true clinical significance of this 
remains unclear. Given the potential heteroge- 
neous aetiology of SUDEP and the possibility 
that not every EEG discharge significantly affects 
the QTc, to ascertain the true clinical significance 
of this finding, a larger study, using 12 lead ECG 
to look for QT dispersion and with greater 
numbers needs to be undertaken. In the mean- 
time the question is tentatively raised that 
identification of at-risk subjects might enable use 
of prophylactic medication. 
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